It was reported that a progav 2.0 shunt system (#fx597t) was implanted during a procedure performed on (b)(6) 2022.According to the complainant, the shunt system showed an under-drainage and adjustment difficulties.The patient underwent a revision procedure performed on (b)(6) 2024.The complainant device has returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 2 years, 9 months.Weight: 10.7 kilograms.Height: 89 centimeters.Gender: female.
|
Visual inspection: no significant deformations or damage to the progav 2.0 and the shuntassistant 2.0 were detected during the investigation.Bloody residues were found in the ped.Prechamber.Permeability test: a permeability test has shown that the progav 2.0 has a blackage while the shuntassistant 2.0 and the ped.Prechamber are permeable.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.The results show that the shuntassistant 2.0 operates within the specified tolerances in the vertical position.Because the progav 2.0 is not permeable, a computer controlled test is not possible.Adjustment test: the progav 2.0 was tested and is not adjustable.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected; however, the breaking force cannot be measured due to the non-adjustability of the valve.Internal inspection: after dismantling of the valves, deposits were found in both valves.To make the deposits in the shunt system more visible, they were colored using a staining solution.Results: in advance, we would like to point out that the product sent in was not inserted in liquid at the time of delivery.Dried deposits can influence the function of the products, which can affect the results.Despite this, we have examined the valve.Based on our test results, we can determine a blockage and non-adjustability on the progav 2.0.The deposits visible in the valve may have led to the functional impairment.Deposits caused by natural substances in the body, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of proteins can impair the integrity of the valve.Based on our test results, we can detect visible deposits in the shuntassistant 2.0 and in the pred.Prechamber.The deposits did not affect the technical properties at the time of the investigation.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|